Abstract
The aberration of cytoskeletal systems is speculated in the pathogenesis of Alzheimer’s disease (Selkoe,1989). In this present report, we communicate, 1) the presence of higher titers of IgG antibody against glial fibrillary acidic protein (GFAP) in Alzheimer sera than in control sera and further characterization of the lympocytes from Alzheimer patients, 2) aberration of vimentin fiber arrangement in Alzheimer fibroblasts, and 3) characterization ofneurofilament fibers observed in aluminum encephalopathy in rabbit brain. From these independent findings about intermediate filaments in the central nervous system, we also the author will discuss the possible involvement of intermediate filament aberration in Alzheimer pathogenesis.Ministry of Education of Japan.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kingsley B.S.,Gaskin F.,and Fu S.M., Human antibodies to neurofibrillay tangles and astrocytes in Alzheimer’s disease.JNeuroimmunol 19: 89, (1988).
Klatzo,I.,11isniewski H.,and Streicher E., Experimetnalproduction of neurofibrillary degeneration. J Neuropathol Exp Neurol 24:187,(1965).
Lowe J.,Blanchard A.,Morrell K.,Lennox G.,Reynolds L.,Billett M.,Landon M.,and Mayer J., Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man,including those of Parkinson’s disease, Pick’s disease,and Alzheimer’s disease, as well as Rosenthal fibers in cerebellar astrocytomas,cytoplasmic bodies in muscle,and Mallory bodies in alcoholic liver disease. J Pathol 155: 9, (1988).
Mori H.,Kondo J.,Ihara Y.,Ubiquitin is a component of paired helical filaments in Alzheimer’s disease. Science 235: 1641, (1987).
Perry G.,Friedman R.,Shaw G.,Chau V.,Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brain.Proc.Natl.Acad.Sci.USA 84:3033, (1987).
Selkoe D.J.,Biochemistry of altered brain proteins in Alzheimer’s disease. Ann Rev Neurosci 12: 463, (1989).
Tanaka J.,Murakoshi K.,Takeda M.,Kato Y.,Tada K.,Hariguchi S.,and Nishimura T.,A high level of anti-GFAP autoantibody in the serum of patients with Alzheimer’s disease.Biomed Res 9:209,(1988).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Plenum Press, New York
About this chapter
Cite this chapter
Nishimura, T., Takeda, M., Nakamura, K., Tanaka, J., Nakamura, Y., Kudo, T. (1990). Some Findings on Intermediate Filaments in Alzheimer’s Disease. In: Nagatsu, T., Fisher, A., Yoshida, M. (eds) Basic, Clinical, and Therapeutic Aspects of Alzheimer’s and Parkinson’s Diseases. Advances in Behavioral Biology, vol 38A. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5844-2_25
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5844-2_25
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5846-6
Online ISBN: 978-1-4684-5844-2
eBook Packages: Springer Book Archive